Genetic Disease

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

Conditions:   Retinitis Pigmentosa;   Usher Syndrome Type 2;   Deaf Blind;   Retinal Disease;   Eye Diseases;   Eye Diseases, Hereditary;   Eye Disorders Congenital;   Vision Disorders
Interventions:   Drug: QR-421a;   Other: Sham-procedure
Sponsor:   ProQR Therapeutics
Not yet recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

January 13, 2019 / by / in
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Condition:   Atopic Dermatitis
Interventions:   Drug: Delgocitinib cream;   Drug: Delgocitinib cream vehicle
Sponsor:   LEO Pharma
Recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

January 8, 2019 / by / in
Antidepressant Discontinuation in Treatment Resistant Depression

Condition:   Treatment Resistant Depression
Interventions:   Other: Discontinuation of serotonergic antidepressants;   Other: Continuation of serotonergic medications
Sponsor:   University of Louisville
Not yet recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 27, 2018 / by / in